Dr. Katrin Rauen, Scientific relationship
Dr. med. Katrin Rauen is Fellow of the European Board of Neurology, consultant in Neurology and Psychiatry at the Department of Geriatric Psychiatry, University Hospital of Psychiatry Zurich “Burghölzli”, scientifically specializing on the neuroinflammatory and neurodegenerative long-term sequels following Traumatic Brain Injury (TBI). Dr. Rauen is holding a dual affiliation as Principal Investigator to the Institute of Regenerative Medicine at the University of Zurich (IREM), Switzerland, as well as to the Institute of Stroke and Dementia Research (ISD) at the Ludwig-Maximilians-University, Munich, Germany.
The overarching goal of Dr. Rauen´s research is to elucidate the pathophysiology of chronic TBI and to elucidate biomarkers to better stratify patients being at risk for posttraumatic cognitive decline, thereby setting the basis for new anti-inflammatory and anti-dementia therapy. Furthermore, she aims to implement neuro-psychiatric diagnostic algorithm to early identify patients being at risk for psychiatric disorders to support patients and their caregivers to adapt to the posttraumatic condition and to regain best quality of life despite the lifechanging brain trauma.
Dr. Rauen received her M.D. in 2011 from Ludwig-Maximilians-University, Munich, Germany and gained international experience at the UCL Queens Square Institute of Neurology, London, England, at Kaiser Permanente Rehab Center, Vallejo, California, USA, and at the University of Stellenbosch, South Africa. Her doctoral thesis Influence of vasopressin receptors and aquaporins on secondary brain injury following experimental TBI at Professor Plesnila´s laboratory at LMU Munich was honored summa cum laude in 2014. Dr. Rauen received honors and awards from the German Society of Neurology, German Society of Neurosurgery, International Neurotrauma Society, German Society of Neuroscience, European Academy of Neurology and European Brain Injury Consortium (EBIC). She is part of the ERA-Net Neuron CnsAflame TBI consortium on neuroinflammatory mechanisms following TBI and executive board member of the Women´s Brain Project to elucidate sex and gender differences following TBI.